Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Diabetes|May 15, 2013
Limitations of IL-2 and rapamycin in immunotherapy of type 1 diabetesAudrey Baeyens, Louis Pérol, Gwladys Fourcade, et al.
Frontiers in Immunology|April 6, 2019
TLR3 Activation of Intratumoral CD103<sup>+</sup> Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor ImmunityEmiliano Roselli, Paula Araya, Nicolás Gonzalo Núñez, et al.
European Journal of Immunology|October 16, 2012
Carbon monoxide-treated dendritic cells decrease β1-integrin induction on CD8⁺ T cells and protect from type 1 diabetesThomas Simon, Sylvie Pogu, Virginie Tardif, et al.
Cancer Immunology Research|December 6, 2018
CD16<sup>+</sup>NKG2A<sup>high</sup> Natural Killer Cells Infiltrate Breast Cancer-Draining Lymph NodesAlexandra Frazao, Meriem Messaoudene, Nicolas Nunez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 7, 2004
An altered self-peptide with superagonist activity blocks a CD8-mediated mouse model of type 1 diabetesAgnès Hartemann-Heurtier, Lennart T Mars, Nadège Bercovici, et al.
Plos One|April 15, 2016
Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 ExpressionJérémie D Goldstein, Aude Burlion, Bruno Zaragoza, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant toleranceEliane Piaggio, Lennart T Mars, Cécile Cassan, et al.
Immunity|May 13, 2008
Central role of defective interleukin-2 production in the triggering of islet autoimmune destructionQizhi Tang, Jason Y Adams, Cristina Penaranda, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2014
Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune contextAudrey Baeyens, David Saadoun, Fabienne Billiard, et al.
Pageof 9